- Home
- DCTH vs WIW Comparison
DCTH vs WIW Comparison
Compare DCTH & WIW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DCTH
- WIW
- Stock Information
- Founded
- DCTH 1988
- WIW 2004
- Country
- DCTH United States
- WIW United States
- Employees
- DCTH N/A
- WIW N/A
- Industry
- DCTH Medical/Dental Instruments
- WIW Finance Companies
- Sector
- DCTH Health Care
- WIW Finance
- Exchange
- DCTH Nasdaq
- WIW Nasdaq
- Market Cap
- DCTH 518.0M
- WIW 528.6M
- IPO Year
- DCTH N/A
- WIW N/A
- Fundamental
- Price
- DCTH $14.88
- WIW $8.70
- Analyst Decision
- DCTH Strong Buy
- WIW
- Analyst Count
- DCTH 4
- WIW 0
- Target Price
- DCTH $22.25
- WIW N/A
- AVG Volume (30 Days)
- DCTH 356.0K
- WIW 229.9K
- Earning Date
- DCTH 03-06-2025
- WIW 01-01-0001
- Dividend Yield
- DCTH N/A
- WIW 11.14%
- EPS Growth
- DCTH N/A
- WIW N/A
- EPS
- DCTH N/A
- WIW N/A
- Revenue
- DCTH $22,644,000.00
- WIW N/A
- Revenue This Year
- DCTH $1,672.40
- WIW N/A
- Revenue Next Year
- DCTH $116.33
- WIW N/A
- P/E Ratio
- DCTH N/A
- WIW N/A
- Revenue Growth
- DCTH 945.91
- WIW N/A
- 52 Week Low
- DCTH $3.70
- WIW $8.01
- 52 Week High
- DCTH $16.97
- WIW $9.37
- Technical
- Relative Strength Index (RSI)
- DCTH 46.47
- WIW 57.62
- Support Level
- DCTH $15.50
- WIW $8.62
- Resistance Level
- DCTH $16.43
- WIW $8.75
- Average True Range (ATR)
- DCTH 0.72
- WIW 0.07
- MACD
- DCTH -0.25
- WIW -0.00
- Stochastic Oscillator
- DCTH 2.79
- WIW 70.00
About DCTH Delcath Systems Inc.
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.
About WIW Western Asset Inflation-Linked Opportunities & Income Fund
Western Asset Inflation-Linked Opportunities and Income Fund is a diversified, closed-end management investment company. Its primary investment objective of the group is to provide current income for its shareholders. The secondary investment objective is capital appreciation with current income.